PARSIPPANY, N.J., July 1 - Data published in the journal, Nicotine and Tobacco Research, shows that many U.S. quit attempts are unplanned and can be a successful route to cessation. In the study, almost 40 percent of subjects reported that their most recent quit attempt started without any advance planning, suggesting that for some smokers, setting an advance quit date may not be as necessary as once thought.
While a period of planning prior to quitting has long been thought to allow smokers time to prepare themselves for their quit attempt, the study explores the various reasons as well as demographic and psychographic data which may contribute to a smoker deciding to quit spontaneously.
"The study examines the possibility that while quit attempts may seem like spontaneous efforts on the surface, they may actually be the result of prolonged subconscious dissatisfaction with or concern about one's smoking. The results do not discredit planning out a quit attempt, however, a smoker needs to determine what may be the best approach to ensure long-term cessation," said Dr. Saul Shiffman, professor in the departments of psychology and pharmaceutical science at the
Smokers who make an unplanned quit attempt can improve their chances significantly by getting help and support from proven stop smoking tools such as therapeutic nicotine products like Nicorette(R), NicoDerm(R) CQ(R) and Commit(R). Consistent with their FDA-approved labeling, therapeutic nicotine products help reduce nicotine withdrawal symptoms, including nicotine craving, associated with quitting smoking. Smokers who quit spontaneously can also access therapeutic nicotine medicines which are available over the counter without a doctor's prescription at more than 35,000 retail outlets.
About the Study
A study of 1,700 adults (900 adults age 18 and over who currently smoke cigarettes every day and 800 adults, age 18 and over, who previously smoked every day but quit between one month and ten years ago) were recruited from an online U.S. market research database (Survey Sampling International, Shelton, CT) and completed an online survey. Random samples of both panels were sent an e-mail that contained a link to an online survey.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples -- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.
Contacts: Mark Polisky, GolinHarris 312-729-4417 firstname.lastname@example.org Debbie Bolding, GlaxoSmithKline Consumer Healthcare 412-200-3872 email@example.com
|SOURCE GlaxoSmithKline Consumer Healthcare|
Copyright©2009 PR Newswire.
All rights reserved